Clinical Trial Update: N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19) [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating N-Acetyl Glucosamine as a therapeutic intervention for COVID-19 has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• N-Acetyl Glucosamine (N-Acetyl Glucosamine)

Snippet

Sponsor: Quantinosis.ai LLC | Conditions: Coronavirus, Covid19 | Phase 1 | Status: COMPLETED | Results posted: 2021-11-04